February 10, 2015
Imprivata launched Imprivata Confirm ID, a comprehensive product that enables health practitioners to electronically prescribe controlled substances.
Xenit provides IT infrastructure specialists and market-leading products to assist businesses toward increased efficiency and greater mobility.
One way to describe our business is to say that Xenit assists businesses to implement desired changes for a more efficient and secure use of IT. Another way to say what we do is that we deliver IT solutions that provide greater efficiency through improved end user experience and increased availability of mission-critical systems.
Lexington, Mass.—February 11, 2015—Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced a revised date for its fourth quarter and the full year ended December 31, 2014 conference call. Imprivata will now hold a conference call for investors on Tuesday, February 24 at 5:00 p.m. ET during which management will review highlights from the company's fourth quarter and year end 2014 results, its business outlook and other matters. The Company expects to issue the earnings release after the market closes on Tuesday, February 24, 2015.
February 11, 2015
Imprivata has launched a new product to enable a major shift from paper to elctronic prescribing of controlled substances.
Symantec Norton Secure Login and Symantec VIP Integrate with Imprivata Confirm ID to Simplify Provider Identity-Proofing and Credentialing Workflows to help meet Regulatory Requirements for EPCS
Imprivata announced a partnership with Symantec to provide a comprehensive fingerprint biometric and FICAM-certified Credential Service Provider (CSP) solution for electronic prescribing of controlled substances.
2/10/2015
Lexington, Mass. — February 26, 2015— Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced that members of management will participate in the upcoming Barclays Global Healthcare Conference.
Omar Hussain, President and CEO, and Jeff Kalowski, Chief Financial Officer, will present at the conference in Miami, FL on Wednesday, March 11th at 3:50 PM EST.
An audio webcast of the presentation will be available live and archived on Imprivata’s investor relations website at http://investor.imprivata.com